The insurers I’ve seen that have already listed Daybue on their formulary lists not only require Prior Authorisation - meaning the treating physician must obtain advance approval from the health insurer to determine if the patient qualifies for payment coverage - but also limit quantity to a 30 day supply per fill. One fund states that the quantity limit is to monitor possible adverse effects and to avoid medication waste.
Daybue Rollout, page-81
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.95 |
Change
0.550(3.82%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $14.98 | $14.60 | $3.500M | 236.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 750 | $14.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.95 | 419 | 2 |
View Market Depth
| Last trade - 10.38am 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |